Global Sepsis Diagnostics Market Size study, by Product (Blood Culture Media, Assays & Reagents, Instruments, Software), by Technology (Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, Biomarkers) and Regional Forecasts 2022-2028
Global Sepsis Diagnostics Market is valued at approximately USD 461.47 million in 2021 and is anticipated to grow with a healthy growth rate of more than 9.00% over the forecast period 2022-2028. Sepsis can be defined as the body's reaction to infection as bacterial, viral, fungal, parasitic which may lead to a systemic inflammatory reaction and eventually organ dysfunction and/or failure. The rising incidence of hospital-acquired infections and high incidence of sepsis has led to the adoption of Sepsis Diagnostics across the forecast period. For Instance: as per the CDC incidence of sepsis among hospitalized patients is rising by 8.7% per year. It is estimated that there are more than 1,000,000 incidences of sepsis among hospitalized patients annually in the nation {Source: CDC, 2018). With the rapid increase in HAIs worldwide. Also, with the development of rapid diagnostic and growth opportunities in emerging economies, the adoption & demand for Sepsis Diagnostics is likely to increase the market growth during the forecast period. However, lack of skilled professionals and high cost of automated diagnostic devices impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Sepsis Diagnostics market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the presence of a highly developed healthcare system, high adoption of innovative sepsis diagnostic technologies. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as rising number of surgical procedures, increasing incidence of healthcare-associated infections would create lucrative growth prospects for the Sepsis Diagnostics market across Asia-Pacific region.
Major market players included in this report are:
Axis-Shield Diagnostics (UK)
Becton, Dickinson and Company (US)
Danaher Corporation (US)
Thermo Fisher Scientific (US)
Bruker Corporation (US)
Abbott Laboratories (US)
Axis-Shield Diagnostics (UK)
Quidel Corporation (US)
EKF Diagnostics (UK)
Seegene Inc. (South Korea)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Blood Culture Media
Assays & Reagents
Instruments
Software
By Technology:
Blood Culture
Immunoassays
Molecular Diagnostics
Flow Cytometry
Microfluidics
Biomarkers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Sepsis Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Companies Mentioned
Axis-Shield Diagnostics (UK)
Becton, Dickinson and Company (US)
Danaher Corporation (US)
Thermo Fisher Scientific (US)
Bruker Corporation (US)
Abbott Laboratories (US)
Axis-Shield Diagnostics (UK)
Quidel Corporation (US)
EKF Diagnostics (UK)
Seegene Inc. (South Korea)
Please note:The single user license is non-downloadable and non-printable. Global Site license will allow these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook